by admin_63069 | Mar 4, 2021 | Articles of Interest
All patients with active cancer, or with active, recent, or planned cancer treatment, should be considered highest priority to receive one of the coronavirus disease 2019 vaccines that have been granted emergency use authorization from the FDA.
by admin_63069 | Mar 3, 2021 | News You Can Use
Lynparza demonstrates a significantly longer duration of survival compared Xtandi or Zytiga for men with metastatic prostate cancer, one study found.
by admin_63069 | Mar 1, 2021 | Articles of Interest
Treatment is described as the “single biggest change in the last 20 years”
by admin_63069 | Mar 1, 2021 | Resources
Highlights from the 27th Annual Prostate Cancer Foundation Scientific Retreat
by admin_63069 | Feb 28, 2021 | Related Topics
Discharging patients the same day that they undergo robotic urologic surgery during the COVID-19 pandemic did not increase their risk for complications or readmission, a study found.
